-
Mashup Score: 231How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement - 26 day(s) ago
Reimbursement is a key factor in defining which resources are made available to ensure quality, efficiency, availability, and access to specific health-care interventions. This Policy Review assesses publicly funded radiotherapy reimbursement systems in Europe. We did a survey of the national societies of radiation oncology in Europe, focusing on the general features and global structure of the reimbursement system, the coverage scope, and level for typical indications. The annual expenditure covering radiotherapy in each country was also collected.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 18
Our findings suggests that systematic endoscopic mediastinal staging in patients with locally advanced or unresectable NSCLC is more accurate than PET alone in defining extent of mediastinal involvement. Standard guideline-recommended PET-based radiotherapy planning results in suboptimal tumour coverage. Our findings indicate that systematic endoscopic staging should be routinely performed in patients with locally advanced NSCLC being considered for radiotherapy to accurately inform radiation planning and treatment decision making in patients with locally advanced NSCLC.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 14Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial - 3 month(s) ago
Patients with glioblastoma who are older or have poor performance status (PS) experience particularly poor clinical outcomes. At the time of study ini…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet-
Thanks @ECMC_UK for opportunity to discuss the many challenges of PARADIGM - biomarker driven randomised study of #radiotherapy + olaparib/placebo in older GBM pts 26 protocol amendments later we've published phase I and recruited 132 of 140 pts to ph II. https://t.co/TrVzHG5MHr https://t.co/3ReR5VTc73
-
-
Mashup Score: 55Consultant Clinical Scientist, Head of Service - Radiotherapy Physics :Beatson West of Scotland Cancer Centre / Gartnavel General Hospital - 3 month(s) ago
Salary: Band 8D (£94,345 – £98,384) NHS Greater Glasgow and Clyde is one of the largest healthcare systems in the UK employing around 40,000 staff in a wide range of clinical and non-clinical professions and job roles. We deliver acute hospital, primary, community and mental health care services to a population of over 1.15 million and a wider population of 2.2 million when our regional and national services are included. Applications are invited to join our dynamic, forward thinking and friendly team as
Source: apply.jobs.scot.nhs.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3Targeted Radiotherapy Appropriate First Therapy for Some GEP-NETs | Cancer Discovery News | American Association for Cancer Research - 4 month(s) ago
Abstract: Radioligand therapy with [177Lu]Lu-DOTA-TATE and octreotide extends progression-free survival and improves overall response rates in patients with gastroenteropancreatic neuroendocrine tumors compared with high-dose octreotide alone. The success of this approach may provide a model for new first-line approaches in other advanced malignancies. DOI: https://doi.org/10.1158/2159-8290.CD-NB2024-0001 You do not currently have access to this content. Don’ t already have an account? Register You could
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 100Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis - 4 month(s) ago
Symptomatic arrhythmia is common following radiotherapy for non-small cell lung cancer (NSCLC), frequently resulting in morbidity and hospitalization.…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 57Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses - 6 month(s) ago
A single institution retrospective study suggested that head and neck squamous cell cancer (HNSCC) patients receiving radiotherapy (RT) during “dark” …
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate - 7 month(s) ago
PURPOSE The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR using different surrogacy analytic methods. MATERIALS AND METHODS Individual patient data from 11 trials evaluating radiotherapy dose escalation, androgen deprivation therapy (ADT) use, and ADT prolongation were obtained. Surrogate candidacy was assessed using the Prentice criteria (including landmark analyses) and the two-stage meta-analytic approach (estimating Kendall’s tau and the R2). Biochemical recurrence-free survival (BCRFS, time from random assignment to BCR or any death) and time to BCR (TTBCR, time from random assignment to BCR or cancer-specific deaths censoring for noncancer-related deaths) were assessed. RESULTS Overall, 10,741 patients were included. Dose escalation, addition of short-term ADT, and prolongation of ADT duration significantly improved BCR (hazard ratio [HR], 0.71 [95% CI, 0.63 to 0.79]
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Long-Term Safety and Efficacy Is Reported With Partial-Breast Radiotherapy in Early-Stage Breast Cancer - 7 month(s) ago
Reduced-dose or partial-breast radiotherapy showed comparable safety and efficacy outcomes compared with whole-breast radiotherapy.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Approach to Palliative Radiation Plans Reduces the Amount of Time Patients Spend in Treatment Centers - 7 month(s) ago
Using diagnostic CT scans to create palliation plans may save time and improve the patient experience.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
What I learned in 🇨🇱 today … $5mill = one #radiotherapy machine☢️, can treat 10k patients. $5mill = 135 patients worth of trastuzumab. 🧐 @TheLancetOncol - https://t.co/qyAG8X6Rdq “an essential pillar in multi-D oncology…an inexpensive modality” - 👏🏽 well said @TargetingCancer https://t.co/yxqNP9FEkA